Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clearside Biomedi (NQ: CLSD )

1.340 +0.030 (+2.29%)
Streaming Delayed Price Updated: 12:05 PM EDT, May 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 55,397
Open 1.310
Bid (Size) 1.330 (10)
Ask (Size) 1.340 (5)
Prev. Close 1.310
Today's Range 1.310 - 1.350
52wk Range 0.6501 - 2.120
Shares Outstanding 61,666,130
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
Via Benzinga
CLSD Stock Earnings: Clearside Biomedical Misses EPS, Misses Revenue for Q1 2024
CLSD stock results show that Clearside Biomedical missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+3.88%
+3.88%
1 Month
+2.29%
+2.29%
3 Month
+3.88%
+3.88%
6 Month
+37.90%
+37.90%
1 Year
-4.29%
-4.29%

More News

Read More
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
3 Penny Stocks That Insiders Are Buying
Via MarketBeat
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Clearside Biomedical: Q4 Earnings Insights
Via Benzinga
Preview: Clearside Biomedical's Earnings
Via Benzinga
Clearside Biomedical: Q3 Earnings Insights
Via Benzinga
Clearside Biomedical's Earnings: A Preview
Via Benzinga
7 Top Stocks Under $7
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Earnings Scheduled For March 12, 2024
Via Benzinga
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Top 5 Health Care Stocks That May Crash This Month
Via Benzinga
Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness
Via Benzinga
Over $2M Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Topics Stocks
Exposures US Equities
3 Cheap Stocks to Buy Under $1 in October 2023
Via InvestorPlace
Earnings Scheduled For November 13, 2023
Via Benzinga
Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Clearside Biomedical And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.